# MCL 15.676

IRI: <https://ontology.bommaritollc.com/id/01a0d566-5406-74b7-92ea-7131dc4a966a>

Type: [schema:Legislation](https://schema.org/Legislation)

- `adms:identifier`: [mcl-object mcl-15-676](https://ontology.bommaritollc.com/id/01a0d566-5406-74b7-92ea-71400ec24689)
- `prov:wasDerivedFrom`: [evidence from https://www.legislature.mi.gov/Laws/MCL?objectName=mcl-15-676](https://ontology.bommaritollc.com/id/01a0d566-5406-74b7-92ea-713028ce72c4)
- `schema:isPartOf`: [2019 PA 39](https://ontology.bommaritollc.com/id/01a0d565-2789-72c6-9be2-b966c6b3fab5)
- `schema:legislationIdentifier`: MCL 15.676
- `schema:legislationJurisdiction`: [Michigan](https://ontology.bommaritollc.com/id/01a0ca47-57ff-7219-9e2f-cdc1b39bd0fa)
- `schema:legislationLegalForce`: [schema:InForce](https://schema.org/InForce)
- `schema:legislationType`: [MCL section](https://ontology.bommaritollc.com/vocab/leg/mclSection)
- `schema:name`: Distribution of opioid antagonist.
- `schema:url`: [https://www.legislature.mi.gov/Laws/MCL?objectName=mcl-15-676](https://www.legislature.mi.gov/Laws/MCL?objectName=mcl-15-676)
- `skos:prefLabel`: MCL 15.676

## Pointing here

- `eli:changes`:
  - [2024 PA 231](https://ontology.bommaritollc.com/id/01a0d565-56e2-744f-83a6-485967b57b2d)
- `schema:legislationChanges`:
  - [HB 4737 (2023-2024)](https://ontology.bommaritollc.com/id/01a0d568-a6ce-7718-89e5-619241cd2526)

---
Also as: [Turtle](https://ontology.bommaritollc.com/id/01a0d566-5406-74b7-92ea-7131dc4a966a.ttl), [JSON-LD](https://ontology.bommaritollc.com/id/01a0d566-5406-74b7-92ea-7131dc4a966a.jsonld), [N-Triples](https://ontology.bommaritollc.com/id/01a0d566-5406-74b7-92ea-7131dc4a966a.nt), [HTML](https://ontology.bommaritollc.com/id/01a0d566-5406-74b7-92ea-7131dc4a966a)
Release 0.1.0-rc2, graph hash 7bff5cca52a15f9423935489ca422d65f7c8da603f464bd08273a8caa6d3175a.
